References
- Glimelius B. 50 years with Acta Oncologica. Acta Oncol 2013;52:1–2.
- Glimelius B. The 50-year anniversary of Acta Oncologica. Acta Oncol 2014;53:1–2.
- Muren LP, Teras M, Knuuti J. NACP 2014 and the Turku PET symposium: The interaction between therapy and imaging. Acta Oncol 2014;53:993–6.
- Grau C, Hoyer M, Alber M, Overgaard J, Lindegaard JC, Muren LP. Biology-guided adaptive radiotherapy (BiGART) – more than a vision? Acta Oncol 2013;52:1243–7.
- Dalton SO, Johansen C. New paradigms in planning cancer rehabilitation and survivorship. Acta Oncol 2013;52:191–4.
- Deasy JO, Muren LP. Advancing our quantitative understanding of radiotherapy normal tissue morbidity. Acta Oncol 2014;53:577–9.
- Muren LP, Rossi C, Hug E, Lee A, Glimelius B. Establishing and expanding the indications for proton and particle therapy. Acta Oncol 2013;52:459–62.
- Muls AC. Acta Oncologica Lecture. Gastrointestinal consequences of cancer treatment and the wider context: A bad gut feeling. Acta Oncol 2014;53:297–306.
- Glimelius B, Johansen C, Muren LP, Nilbert M. Acta Oncologica and a new generation of scientists in oncology. Acta Oncol 2014;53:849–51.
- Therkildsen C, Bergmann TK, Henrichsen-Schnack T, Ladelund S, Nilbert M. The predictive value of KRAS, NRAS, BRAF, PIK3CA and PTEN for anti-EGFR treatment in metastatic colorectal cancer: A systematic review and meta-analysis. Acta Oncol 2014;53:852–64.
- Bockelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B. Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature. Acta Oncol 2015;54:5–16.
- Poulsen LO, Qvortrup C, Pfeiffer P, Yilmaz M, Falkmer U, Sorbye H. Review on adjuvant chemotherapy for rectal cancer – why do treatment guidelines differ so much? Acta Oncol 2015;54:437–46.